Dramatic efficiency of pegylated interferon in sinus histiocytosis with massive lymphadenopathy.
Le Guenno
G
G
Galicier
L
L
Fieschi
C
C
Meignin
V
V
Chabrol
A
A
Oksenhendler
E
E
D000328:Adult; D000744:Anemia, Hemolytic, Autoimmune / Q000150:complications; D001706:Biopsy; D005260:Female; D015618:Histiocytosis, Sinus / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008875:Middle Aged; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D011994:Recombinant Proteins; D016896:Treatment Outcome
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C100416:peginterferon alfa-2a